<prompt> A patient with Renal cell carcinoma is on treatment with Erythropoetin. Erythropoetin use may be associated with all of the following, except:Decreased reticulocytesIncreased hemtocritIncreased hemoglobinEliminates need for transfusion  <response>: Treatment with erythropoietin stimulates erythrocyte production and results in an increase in reticulocyte count. Reticulocyte count is not decreased. So Decreased reticulocytes is the single best answer of choice. Ref: Harrisons Principles of Internal Medicine, 16th Edition, Page 667 